Literature DB >> 11784838

Fear conditioned changes of heart rate in patients with medial cerebellar lesions.

M Maschke1, M Schugens, K Kindsvater, J Drepper, F P Kolb, H-C Diener, I Daum, D Timmann.   

Abstract

Fear conditioned changes of heart rate and skin conductance responses were investigated in patients with medial cerebellar lesions. A classical conditioning paradigm with a tone as the conditioned stimulus (CS) and an electrical shock as the unconditioned stimulus (US) was tested on five patients with medial cerebellar lesions due to surgery for astrocytoma and five controls. The CS preceded the US by 5900 ms and coterminated with the US. Changes in heart rate and skin conductance responses were obtained as measures for autonomic fear responses. Effects of conditioning were quantified by comparison of the habituation and extinction phases. Controls, but not cerebellar patients, showed a significant decrease of heart rate during fear conditioning. However, there were no significant fear conditioned changes in electrodermal responses in either group. In summary, the medial cerebellum seems to be involved in fear-conditioned bradycardia in humans.

Entities:  

Mesh:

Year:  2002        PMID: 11784838      PMCID: PMC1737702          DOI: 10.1136/jnnp.72.1.116

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

Review 1.  Chasing "fear memories" to the cerebellum.

Authors:  Almira Vazdarjanova
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

2.  The impact of orbital prefrontal cortex damage on emotional activation to unanticipated and anticipated acoustic startle stimuli.

Authors:  Nicole A Roberts; Jennifer S Beer; Kelly H Werner; Donatella Scabini; Sara M Levens; Robert T Knight; Robert W Levenson
Journal:  Cogn Affect Behav Neurosci       Date:  2004-09       Impact factor: 3.282

3.  Learning-related long-term potentiation of inhibitory synapses in the cerebellar cortex.

Authors:  Bibiana Scelfo; Benedetto Sacchetti; Piergiorgio Strata
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-09       Impact factor: 11.205

4.  Cerebellar contributions to different phases of visceral aversive extinction learning.

Authors:  Joswin Kattoor; Markus Thürling; Elke R Gizewski; Michael Forsting; Dagmar Timmann; Sigrid Elsenbruch
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

Review 5.  The emotional cerebellum.

Authors:  Piergiorgio Strata
Journal:  Cerebellum       Date:  2015-10       Impact factor: 3.847

6.  Consensus Paper: Cerebellum and Emotion.

Authors:  M Adamaszek; F D'Agata; R Ferrucci; C Habas; S Keulen; K C Kirkby; M Leggio; P Mariën; M Molinari; E Moulton; L Orsi; F Van Overwalle; C Papadelis; A Priori; B Sacchetti; D J Schutter; C Styliadis; J Verhoeven
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

7.  Altered Cerebellar Activity in Visceral Pain-Related Fear Conditioning in Irritable Bowel Syndrome.

Authors:  J Claassen; F Labrenz; T M Ernst; A Icenhour; J Langhorst; M Forsting; D Timmann; S Elsenbruch
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

Review 8.  Neuroimaging Markers of Risk, Disease Expression, and Resilience to Bipolar Disorder.

Authors:  Sophia Frangou
Journal:  Curr Psychiatry Rep       Date:  2019-06-04       Impact factor: 5.285

9.  Constrained Spherical Deconvolution Tractography Reveals Cerebello-Mammillary Connections in Humans.

Authors:  Alberto Cacciola; Demetrio Milardi; Alessandro Calamuneri; Lilla Bonanno; Silvia Marino; Pietro Ciolli; Margherita Russo; Daniele Bruschetta; Antonio Duca; Fabio Trimarchi; Angelo Quartarone; Giuseppe Anastasi
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

10.  Modulatory effects of theta burst stimulation on cerebellar nonsomatic functions.

Authors:  Asli Demirtas-Tatlidede; Catarina Freitas; Alvaro Pascual-Leone; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2011-09       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.